Cure8 research brief
Why This Matters
This study describes long-term outcomes in children with IBD managed at an Egyptian tertiary centre — useful for families and clinicians to understand age at diagnosis, treatment patterns, remission and relapse rates, and risks including sepsis-related deaths.
Who Should Pay Attention
Pediatric patients with IBD, parents and caregivers, pediatric gastroenterologists, and clinicians involved in pediatric IBD care.
Study Snapshot
What To Know
This retrospective single-centre cohort study from Egypt reports characteristics and long-term outcomes for 205 children with IBD diagnosed between 2010–2023. About half had ulcerative colitis and one-third had Crohn’s disease; mean age at diagnosis was 6.4 years with an average diagnostic delay of ~1.6 years.
Biologic therapy was used in 23% of patients; at last follow-up 66% were in remission, 29% had relapsing disease, and 5% had died (six deaths linked to sepsis).
The paper highlights frequent young age at onset, diagnostic delays, extensive disease at presentation, ongoing risks from relapsing disease and corticosteroid exposure, and sepsis as an important cause of mortality.
The study uses standard pediatric activity indices (PCDAI, PUCAI) and relies on chart review at a single tertiary referral centre, which may concentrate more severe cases.
This report describes outcomes in an Egyptian tertiary paediatric referral population; treatment patterns (including biologic use) and mortality related to sepsis may reflect local referral patterns, infection risks, and resource availability rather than broader population rates.
Keep In Mind
Single-centre, retrospective design and tertiary referral setting can overrepresent severe cases; diagnostic delays and infection-related mortality may be influenced by local healthcare factors. Findings are from the article abstract and extracted text.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.